Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,794 total articles
MIRA Pharmaceuticals announced successful completion of 7-day dose-range finding toxicology and toxicokinetic studies of MIRA-55, a novel oral non-opioid drug candidate for inflammatory pain, in rats and dogs. These results support dose selection and the design of subsequent GLP-compliant studies in their IND-enabling program, aiming for FDA Invest…
Asure Software, Inc. has made its Asure Tax solution available on Oracle Marketplace, enabling integration with Oracle Fusion Cloud Human Capital Management (HCM). This integration allows enterprises using Oracle's HR platform to add comprehensive payroll tax and treasury capabilities without switching core payroll systems, offering federal, state,…
Vera Bradley, Inc., a leading women's fashion and accessory designer based in Fort Wayne, Indiana, announced it will report its second quarter fiscal year 2027 financial results on September 15, 2026. The company will host a conference call and webcast to discuss the earnings. Vera Bradley operates through Direct and Indirect segments, serving a br…
Dianthus Therapeutics, a clinical-stage biotech company focused on severe autoimmune diseases, will present at the Wells Fargo Healthcare Conference, Citi Biopharma Back to School Conference, and the Cantor Global Healthcare Conference in September 2026. The company’s executives will engage in one-on-one investor meetings and fireside chats, with p…
Profound Medical Corp., a NASDAQ-listed medical device company specializing in interventional MRI procedures, has appointed Richard Fabian as President. Fabian brings extensive leadership experience in healthcare technology and medical devices, notably from Fujifilm Sonosite and Philips Healthcare. This leadership change aims to enhance the company…
Figure Technology Solutions finalized its acquisition of Kiavi, the leading Residential Transition Loan lender, to enhance its blockchain-based capital marketplace. The integration is expected to broaden access to Kiavi's lending technologies within Figure's extensive ecosystem, accelerating growth in the $35 trillion home equity market. The deal i…
TransUnion's marketing campaign for its TruAudience Marketing Solutions, titled 'Bring Clarity to Chaos,' was named a finalist for the 2026 AdExchanger Awards in the Most Innovative Marketing Campaign category. The campaign's omnichannel strategy effectively connected fragmented marketing ecosystems, engaging B2B buyers across multiple platforms. T…
Septerna, Inc., a clinical-stage biotech focusing on GPCR drug discovery, announced management's participation in two major healthcare investor conferences in September 2026, including live webcasts. The company highlights its proprietary technology platform and diverse pipeline targeting endocrinology, immunology, inflammation, and metabolic disea…
BlackLine, Inc. announced it has achieved PCI DSS compliance validation for its PCI Detokenization Service. This enables organizations to securely automate complex workflows involving sensitive payment card data by combining secure access with BlackLine's high-volume transaction matching and reconciliation technology. The validation allows the comp…
Relmada Therapeutics, a clinical-stage biotech company focusing on oncology and CNS disorders, announced participation in the Wells Fargo Healthcare Conference with senior management conducting one-on-one meetings to discuss their clinical programs and corporate progress.
CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced its management's participation in several prestigious healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, and Morgan Stanley events. The company focuses on developing novel conditionally activated PROBODY therapeutics des…
FTC Solar announced that Enertis Applus+ has independently validated the performance of its SUNPATH® software. The study showed that the optimization software provides consistent and predictable energy gains across utility-scale solar projects in the U.S., with measured energy production increases closely matching modeled estimates. This validation…
Aduro Clean Technologies Inc. reported its fourth quarter and fiscal 2026 results highlighting substantial investments in pilot plant operations, engineering, and project development. The company transitioned its Next Generation Process Pilot Plant into structured operations and progressed its First-of-a-Kind program. Aduro strengthened its financi…
Metagenomi Therapeutics, an in vivo genome editing company, announced that its President and CEO will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference. The company focuses on developing proprietary CRISPR-based genetic medicines, with a lead program targeting hemophilia A showing promising preclinical results.
BIO-key International, a leader in biometric identity and access management solutions, announced that CEO Michael DePasquale will participate in virtual meetings and present at the H.C. Wainwright Global Investment Conference in September 2026. The company's presentation will be available on demand to registered attendees, highlighting its biometri…
Emergent BioSolutions has been awarded a $24 million contract modification by BARDA, part of the U.S. Department of Health and Human Services, to supply its CYFENDUS® anthrax vaccine. This contract supports the U.S. government's ongoing anthrax preparedness efforts amid biological threats. CYFENDUS®, FDA-approved in 2023 for post-exposure prophylax…
Kayne Anderson Energy Infrastructure Fund, Inc. declared a monthly distribution of $0.09 per common share payable on September 30, 2026. The fund focuses on energy infrastructure securities and aims to provide high after-tax returns with an emphasis on cash distributions. Distribution amounts may vary and are subject to Board approval and financial…
Sezzle Inc. announced that Gymshark, Debenhams Group (including its multiple brands), and Follett Higher Education are now offering Sezzle as a payment option at checkout. This expansion comes during a record back-to-school shopping season, providing flexible payment solutions for budget-conscious students and families. With Sezzle's point-of-sale …
3 E Network Technology Group Limited announced that its wholly owned subsidiary secured a $1.2 million sales order for enterprise-grade DDR4 memory chips. This order demonstrates the company's capabilities in hardware supply amid growing IT infrastructure upgrades and provides additional revenue to support its AI infrastructure R&D efforts. The ord…
NorthStrive Biosciences, a subsidiary of PMGC Holdings (NASDAQ: ELAB), announced an expanded three-phase program with Yuva Biosciences to advance four AI-discovered compounds toward lead nomination for developing potential therapies in cardiac diseases and obesity. The program builds upon positive Phase III results and aims to de-risk and narrow ca…
Kala Bio and Virotek announced a letter of intent to establish an exclusive U.S. distribution partnership where Kala will market and distribute Virotek's genetic testing program for ophthalmology. This collaboration aligns with Kala's strategic focus on eye care and provides a near-term commercial revenue opportunity while extending Kala's reach in…
Heidmar Maritime Holdings Corp. reported robust second quarter and first half 2026 results with total revenues of $29.0 million in Q2, a significant increase from $9.6 million in Q2 2025, driven by growth in commercially managed vessels and higher chartering activity. Net income attributable to shareholders rose to $2.2 million in Q2 2026 compared …
Clearmind Medicine Inc. has initiated Phase IIa of its Phase I/IIa clinical trial evaluating CMND-100, a non-hallucinogenic psychedelic-derived therapeutic candidate, for the treatment of Alcohol Use Disorder (AUD). Six patients have been enrolled so far across medical centers in Israel, marking progression into the multiple-dose treatment phase fo…
Vera Therapeutics, a US-based commercial-stage biotech company specializing in autoimmune kidney diseases, will present at the Cantor Global Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September 2026. The company's management aims to engage investors through fireside chats and one-on-one meetings, highlighting their…
Alumis announced that its Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus (SLE) did not meet primary and secondary endpoints in the overall population. However, robust responses in the prespecified interferon gene signature-high (IFNGS-high) subgroup, representing most moderate-to-severe SLE cases, support …
